Skip to main content
Unit of study_

SURG5038: Malignant Breast Disease and MDTs

Breast surgery requires a thorough knowledge of the science and management of malignant breast disease and this unit of study aims to prepare the post fellowship candidate for a career in breast surgery. The content focuses on the pathology and recent advances in the understanding of the pathogenesis of malignant breast disease. You will gain an indepth understanding of available prognostic assessment tools, multidisciplinary care of breast cancer patients ( including adjuvant and neoadjuvant chemotherapy, radiotherapy, endocrine therapy and the integral role of the breast care nurse and other allied health staff) and survivorship issues. Specific surgical decision algorithms and surgical options for malignant and insitu disease will be thoroughly explored and explained.

Code SURG5038
Academic unit Surgery
Credit points 6
Prerequisites:
? 
SURG5037
Corequisites:
? 
None
Prohibitions:
? 
None
Assumed knowledge:
? 
This unit is designed as the first part of a curriculum for contemporary breast surgery for Post Fellowship Trainees and assumes practical skills training is obtained on the BreastSurgANZ PFT Program (or equivalent). Applicants must have completed general or plastic surgical training and have a strong interest in breast surgery

At the completion of this unit, you should be able to:

  • LO1. understand the different histopathology subtypes and prognostic implications of each across the spectrum of breast malignancy
  • LO2. understand the subtleties of management associated with the different subtypes of breast malignancy
  • LO3. demonstrate a comprehensive understanding of and ability to meaningfully contribute to the interactions and recommendations of the multidisciplinary team for your patients’ optimal breast cancer management
  • LO4. demonstrate a solid understanding of the neoadjuvant and adjuvant systemic therapy options
  • LO5. demonstrate a solid and contemporary understanding of adjuvant (and neoadjuvant) radiotherapy options
  • LO6. understand treatment related toxicity and morbidity and how it is best managed
  • LO7. understand the principles of management of locally advanced and breast cancer recurrence
  • LO8. understand the importance of breast care nurse, supportive care, and psycho-oncological colleagues to maximise patient acceptance, tolerance, compliance and quality of life during and after treatment
  • LO9. be aware of evolving management trends, contemporary clinical trials and unresolved management questions for patients with breast malignancy.

Unit outlines

Unit outlines will be available 1 week before the first day of teaching for the relevant session.